← European Medicine Shortage Tracker · all medicines
Olanzapinembonat-Monohydrat currently has availability issues reported in 1 European register: Germany.
Shortage ATC N05AH03 · also listed as: Olanzapinembonat-Monohydrat · data refreshed 7 August 2026
As of 7 August 2026, 1 of the 10 tracked registers list current availability issues for Olanzapinembonat-Monohydrat, covering 3 affected product presentations. Where agencies state a cause, manufacturing problems lead with 3 of the 3 stated-cause reports. The furthest expected-resolution date currently on file is 2026-11-25; the earliest is 2026-10-28. Momentum is current, not historical: 3 of the open reports were filed within the last 90 days. Registers in Germany indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Olanzapinembonat-Monohydrat is coded N05AH03 — a medicine acting on the nervous system — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇩🇪 Germany | Shortage ZYPADHERA 210 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension - OP(483mg+3ml) + 2 more productsZYPADHERA 300 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension - OP(690mg+3ml) ZYPADHERA 405 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension - OP(931mg+3ml) | 2026-07-22 | 2026-11-25 | Probleme in der Herstellung Alternatives: ZYPADHERA 405 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension - OP(931mg+3ml) - Einreichungsnummer: 2705751 | register ↗ |
Every individual register entry for Olanzapinembonat-Monohydrat in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇩🇪 DE | ZYPADHERA 210 mg Pulver und Lösungsmittel zur Herstellung einer Depot- | Shortage | 2026-08-26 | 2026-11-10 | Probleme in der Herstellung |
| 🇩🇪 DE | ZYPADHERA 405 mg Pulver und Lösungsmittel zur Herstellung einer Depot- | Shortage | 2026-08-16 | 2026-11-25 | Probleme in der Herstellung |
| 🇩🇪 DE | ZYPADHERA 300 mg Pulver und Lösungsmittel zur Herstellung einer Depot- | Shortage | 2026-07-22 | 2026-10-28 | Probleme in der Herstellung |
Yes. As of 7 August 2026, availability issues are reported in: Germany. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-10-28 to 2026-11-25. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
3 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency register that lists Olanzapinembonat-Monohydrat: BfArM (Germany). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Olanzapinembonat-Monohydrat — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/olanzapinembonat-monohydrat/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Olanzapinembonat-Monohydrat availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/olanzapinembonat-monohydrat/">Olanzapinembonat-Monohydrat shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>